Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012

Summary

companys clinical trial report, “Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012 provides data on the Metastatic Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Liver Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by companys team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Tables 5
List of Figures 6
Introduction 7
Metastatic Liver Cancer 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Metastatic Liver Cancer 24
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Metastatic Liver Cancer Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
AstraZeneca PLC 33
Clinical Trial Overview of AstraZeneca PLC 33
F. Hoffmann-La Roche Ltd. 34
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 34
Light Sciences Oncology, Inc. 35
Clinical Trial Overview of Light Sciences Oncology, Inc. 35
Sirtex Medical Limited 36
Clinical Trial Overview of Sirtex Medical Limited 36
NS Pharma, Inc. 37
Clinical Trial Overview of NS Pharma, Inc. 37
Gradalis Inc. 38
Clinical Trial Overview of Gradalis Inc. 38
Matrix Pharma (Canada) Inc. 39
Clinical Trial Overview of Matrix Pharma (Canada) Inc. 39
Micromet AG 40
Clinical Trial Overview of Micromet AG 40
AVEO Pharmaceuticals, Inc. 41
Clinical Trial Overview of AVEO Pharmaceuticals, Inc. 41
Matrix Pharmaceutical Research 42
Clinical Trial Overview of Matrix Pharmaceutical Research 42
Provectus Pharmaceuticals, Inc. 43
Clinical Trial Overview of Provectus Pharmaceuticals, Inc. 43
Bayer AG 44
Clinical Trial Overview of Bayer AG 44
Pfizer Inc. 45
Clinical Trial Overview of Pfizer Inc. 45
Merck & Co., Inc. 46
Clinical Trial Overview of Merck & Co., Inc. 46
Biogen Idec Inc. 47
Clinical Trial Overview of Biogen Idec Inc. 47
Celsion Corporation 48
Clinical Trial Overview of Celsion Corporation 48
Boston Scientific Corporation 49
Clinical Trial Overview of Boston Scientific Corporation 49
Clinical Trial Overview of Top Universities / Institutes / Hospitals 50
The University of Texas M. D. Anderson Cancer Center 50
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 50
University Health Network 51
Clinical Trial Overview of University Health Network 51
Radboud University 52
Clinical Trial Overview of Radboud University 52
University of Pittsburgh 53
Clinical Trial Overview of University of Pittsburgh 53
Massachusetts General Hospital 54
Clinical Trial Overview of Massachusetts General Hospital 54
Kyoto University 55
Clinical Trial Overview of Kyoto University 55
University of California, San Diego 56
Clinical Trial Overview of University of California, San Diego 56
University of Michigan Comprehensive Cancer Center 57
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 57
Samsung Medical Center 58
Clinical Trial Overview of Samsung Medical Center 58
University of Heidelberg 59
Clinical Trial Overview of University of Heidelberg 59
Aarhus University 60
Clinical Trial Overview of Aarhus University 60
European Organization for Research and Treatment of Cancer 61
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 61
Kansai Medical University 62
Clinical Trial Overview of Kansai Medical University 62
Cancer Prevention Institute of California 63
Clinical Trial Overview of Cancer Prevention Institute of California 63
Sidney Kimmel Comprehensive Cancer Center 64
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 64
Dana-Farber Cancer Institute 65
Clinical Trial Overview of Dana-Farber Cancer Institute 65
Roswell Park Cancer Institute 66
Clinical Trial Overview of Roswell Park Cancer Institute 66
Odense University Hospital 67
Clinical Trial Overview of Odense University Hospital 67
Royal Marsden Cancer Campaign 68
Clinical Trial Overview of Royal Marsden Cancer Campaign 68
University of Michigan 69
Clinical Trial Overview of University of Michigan 69
Five Key Clinical Profiles 70
Appendix 93
Abbreviations 93
Definitions 93
Research Methodology 94
Secondary Research 94
About company 95
Contact Us 95
Disclaimer 95
Source 96

List of Tables

Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Metastatic Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Metastatic Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Metastatic Liver Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
Metastatic Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14
Metastatic Liver Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 15
Metastatic Liver Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Metastatic Liver Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 17
Metastatic Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Metastatic Liver Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 19
Metastatic Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Metastatic Liver Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24
Metastatic Liver Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25
Metastatic Liver Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26
Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 33
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 34
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Light Sciences Oncology, Inc., 2012* 35
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sirtex Medical Limited, 2012* 36
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NS Pharma, Inc., 2012* 37
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Gradalis Inc., 2012* 38
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Matrix Pharma (Canada) Inc., 2012* 39
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Micromet AG, 2012* 40
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AVEO Pharmaceuticals, Inc., 2012* 41
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Matrix Pharmaceutical Research, 2012* 42
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Provectus Pharmaceuticals, Inc., 2012* 43
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 44
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 45
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 46
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2012* 47
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celsion Corporation, 2012* 48
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Scientific Corporation, 2012* 49
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 50
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012* 51
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012* 52
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 53
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 54
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012* 55
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2012* 56
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2012* 57
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2012* 58
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2012* 59
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2012* 60
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012* 61
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kansai Medical University, 2012* 62
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Prevention Institute of California, 2012* 63
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012* 64
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 65
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 66
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2012* 67
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Marsden Cancer Campaign, 2012* 68
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2012* 69

List of Figures

Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Metastatic Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Metastatic Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Metastatic Liver Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13
Metastatic Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 14
Metastatic Liver Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Metastatic Liver Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Metastatic Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Metastatic Liver Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Metastatic Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28
Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30
Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
company Methodology 94